VRCA   $0.66  -5.71% Market Open

Verrica Pharmaceuticals Inc
Total Cash 22.96M
totalCashPerShare 0.491
EBITDA -74.19M
Total Debt 0.00
quickRatio
currentRatio
Total Revenue 9.21M
debtToEquity
Revenue/Share 0.198
ROA -0.72178
ROE -20.598888
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins -1.46276
ebitdaMargins 0.0
operatingMargins 11.62493
profitMargins 0.0
enterpriseValue 14.37M
forwardPE -0.921358
floatShares 18.96M
sharesOutstanding 42.67M
sharesShort 4.53M
sharesShortPriorMonth 3.25M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.34%
heldPercentInstitutions 0.44%
Short Ratio help_outline 4.13%
shortPercentOfFloat 0.24%
impliedSharesOutstanding
bookValue -0.728
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -84.99M
trailingEps -1.84%
forwardEps -0.81%
enterpriseToEbitda -0.19
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.34 4Q 2024
institutionsCount 99
lastUpdated Nov. 7, 2024, 2:50 a.m.